Innovation1 Biotech

Innovation1 Biotech Dividend

Dividend of Innovation1 Biotech (IVBT) as of Nov 18, 2026.

Dividend

0.00USD

Last updated:

How much dividend does Innovation1 Biotech 2026 pay?

According to the latest status from November 2026, Innovation1 Biotech paid a total of 0.00 USD per share in dividends within the last 12 months. With the current Innovation1 Biotech price of 0.00 USD, this corresponds to a dividend yield of - %. A dividend is paid times per year.

Historical Innovation1 Biotech Dividends

Historical Innovation1 Biotech Dividends
PaydateDividend

The Innovation1 Biotech Dividend history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Date
Dividend
Jan 1, 2016
0.00 USD
Jan 1, 2017
0.00 USD
Jan 1, 2018
0.00 USD
Jan 1, 2019
0.00 USD
Jan 1, 2020
0.00 USD
Jan 1, 2021
0.00 USD
Jan 1, 2022
0.00 USD
Jan 1, 2023
0.00 USD
The Innovation1 Biotech Dividend history
YEARDividendYoY
0.00USD—
0.00USD—
0.00USD—
0.00USD—
0.00USD—
0.00USD—
0.00USD—
0.00USD—

Is the Innovation1 Biotech Dividend Safe?

Innovation1 Biotech has been increasing the dividend for 0 years.

Analysts expect a Dividend Cut of -100.00% for the current fiscal year.

Dividend Details

Understanding Innovation1 Biotech's Dividend Distributions

Innovation1 Biotech’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Innovation1 Biotech's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Innovation1 Biotech's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Innovation1 Biotech’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Innovation1 Biotech Stock analysis

What does Innovation1 Biotech do? Innovation1 Biotech, Inc. develops modified Schedule 1 molecules from botanical sources, creating synthetic derivatives for neurologic, psychiatric, dermatologic, and ophthalmologic disorders. The company offers five preclinical prodrugs: a mushroom-derived psychedelic prodrug for PTSD and depression, a cannabinoid and tree bark-derived psychedelic prodrug for addiction, and three cannabinoid prodrugs targeting refractory pediatric epilepsy, hypertrophic scarring, and ocular inflammation. These products are based on synthetic derivatives of natural molecules like psilocin from mushrooms and synthetic tetrahydrocannobivarin from Cannabis, with no botanical sourcing in the final products. The company's clients are pharmaceutical firms seeking novel treatments for complex conditions, focusing on neurologic and psychiatric applications. The first prodrug targets PTSD and depression using a synthetic psilocin derivative, while the second combines cannabinoid and tree bark elements for addiction treatment. The third prodrug addresses pediatric epilepsy, scarring, and eye inflammation through cannabinoid-based synthetic compounds. Innovation1 Biotech's revenue comes from licensing its preclinical compounds to pharmaceutical companies for further development and commercialization, with a focus on high-value therapeutic areas like mental health and rare diseases. The company's portfolio emphasizes synthetic chemistry without reliance on direct botanical extraction for its final drug candidates. Innovation1 Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Innovation1 Biotech stock

Innovation1 Biotech paid dividends every year for the past 0 years.

Innovation1 Biotech is assigned to the 'Health' sector.

The dividends of Innovation1 Biotech are distributed in USD.

Dividend calendar 2026

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

All Key Metrics — Innovation1 Biotech